These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 36778566)

  • 21. Clustering of Hypoglycemia Events in Patients With Hyperinsulinism: Extension of the Digital Phenotype Through Retrospective Data Analysis.
    Worth C; Harper S; Salomon-Estebanez M; O'Shea E; Nutter PW; Dunne MJ; Banerjee I
    J Med Internet Res; 2021 Oct; 23(10):e26957. PubMed ID: 34435596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 1 Diabetes: The SWITCH 1 Randomized Clinical Trial.
    Lane W; Bailey TS; Gerety G; Gumprecht J; Philis-Tsimikas A; Hansen CT; Nielsen TSS; Warren M; ;
    JAMA; 2017 Jul; 318(1):33-44. PubMed ID: 28672316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycemic Variability and Hypoglycemic Excursions With Continuous Glucose Monitoring Compared to Intermittently Scanned Continuous Glucose Monitoring in Adults With Highest Risk Type 1 Diabetes.
    Avari P; Moscardo V; Jugnee N; Oliver N; Reddy M
    J Diabetes Sci Technol; 2020 May; 14(3):567-574. PubMed ID: 31375042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Real-time hypoglycemia detection from continuous glucose monitoring data of subjects with type 1 diabetes.
    Jensen MH; Christensen TF; Tarnow L; Seto E; Dencker Johansen M; Hejlesen OK
    Diabetes Technol Ther; 2013 Jul; 15(7):538-43. PubMed ID: 23631608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Approach to Flash Glucose Monitoring: An Expert Recommendation.
    Chico A; Aguilera E; Ampudia-Blasco FJ; Bellido V; Cardona-Hernández R; Escalada FJ; Fernández D; Gómez-Peralta F; González Pérez de Villar N; Gorgojo JJ; Mezquita-Raya P; Morales C; de Pablos Velasco P; Palomares R; Parra J; Rivero MT; González-Blanco C
    J Diabetes Sci Technol; 2020 Jan; 14(1):155-164. PubMed ID: 31081362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe hypoglycemia as a preventable risk factor for cardiovascular disease in patients with type 2 diabetes mellitus.
    Choi SY; Ko SH
    Korean J Intern Med; 2021 Mar; 36(2):263-270. PubMed ID: 32872725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
    Semlitsch T; Engler J; Siebenhofer A; Jeitler K; Berghold A; Horvath K
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005613. PubMed ID: 33166419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoglycemia prevention via pump attenuation and red-yellow-green "traffic" lights using continuous glucose monitoring and insulin pump data.
    Hughes CS; Patek SD; Breton MD; Kovatchev BP
    J Diabetes Sci Technol; 2010 Sep; 4(5):1146-55. PubMed ID: 20920434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapy adjustments in people with type 1 diabetes with impaired hypoglycemia awareness on multiple daily injections using real-time continuous glucose monitoring: a mechanistic analysis of the HypoDE study.
    Waldenmaier D; Freckmann G; Pleus S; Hermanns N; Ehrmann D; Heinemann L; Haug C
    BMJ Open Diabetes Res Care; 2021 Apr; 9(1):. PubMed ID: 33863716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuous Glucose Monitoring-Recorded Hypoglycemia with Insulin Degludec or Insulin Glargine U100 in People with Type 1 Diabetes Prone to Nocturnal Severe Hypoglycemia.
    Brøsen JMB; Agesen RM; Alibegovic AC; Ullits Andersen H; Beck-Nielsen H; Gustenhoff P; Krarup Hansen T; Hedetoft CGR; Jensen TJ; Stolberg CR; Bogh Juhl C; Lerche SS; Nørgaard K; Parving HH; Tarnow L; Thorsteinsson B; Pedersen-Bjergaard U
    Diabetes Technol Ther; 2022 Sep; 24(9):643-654. PubMed ID: 35467938
    [No Abstract]   [Full Text] [Related]  

  • 31. Hypoglycemic Exposure and Risk of Asymptomatic Hypoglycemia in Type 1 Diabetes Assessed by Continuous Glucose Monitoring.
    Henriksen MM; Andersen HU; Thorsteinsson B; Pedersen-Bjergaard U
    J Clin Endocrinol Metab; 2018 Jun; 103(6):2329-2335. PubMed ID: 29618010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Pratley RE; Kanapka LG; Rickels MR; Ahmann A; Aleppo G; Beck R; Bhargava A; Bode BW; Carlson A; Chaytor NS; Fox DS; Goland R; Hirsch IB; Kruger D; Kudva YC; Levy C; McGill JB; Peters A; Philipson L; Philis-Tsimikas A; Pop-Busui R; Shah VN; Thompson M; Vendrame F; Verdejo A; Weinstock RS; Young L; Miller KM;
    JAMA; 2020 Jun; 323(23):2397-2406. PubMed ID: 32543682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of Continuous Glucose Monitoring Trends to Facilitate Exercise in Children with Type 1 Diabetes.
    Burckhardt MA; Chetty T; Smith GJ; Adolfsson P; de Bock M; Jones TW; Davis EA
    Diabetes Technol Ther; 2019 Jan; 21(1):51-55. PubMed ID: 30620642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2018; 18(2):1-160. PubMed ID: 29541282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials.
    Dicembrini I; Cosentino C; Monami M; Mannucci E; Pala L
    Acta Diabetol; 2021 Apr; 58(4):401-410. PubMed ID: 32789691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk Factors of Hypoglycemia in Patients with Type 2 Diabetes Mellitus: A Study Based on Continuous Glucose Monitoring.
    Torimoto K; Okada Y; Hajime M; Tanaka K; Tanaka Y
    Diabetes Technol Ther; 2018 Sep; 20(9):603-612. PubMed ID: 30070933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors associated with nocturnal hypoglycemia in at-risk adolescents and young adults with type 1 diabetes.
    Wilson DM; Calhoun PM; Maahs DM; Chase HP; Messer L; Buckingham BA; Aye T; Clinton PK; Hramiak I; Kollman C; Beck RW;
    Diabetes Technol Ther; 2015 Jun; 17(6):385-91. PubMed ID: 25761202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nocturnal hypoglycemia in type 1 and type 2 diabetes: an update on prevalence, prevention, pathophysiology and patient awareness.
    Siamashvili M; Davis HA; Davis SN
    Expert Rev Endocrinol Metab; 2021 Nov; 16(6):281-293. PubMed ID: 34525888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-Term Home Study on Nocturnal Hypoglycemic Alarms Using a New Fully Implantable Continuous Glucose Monitoring System in Type 1 Diabetes.
    Wang X; Ioacara S; DeHennis A
    Diabetes Technol Ther; 2015 Nov; 17(11):780-6. PubMed ID: 26177299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relation Between Hypoglycemia and Glycemic Variability in Type 2 Diabetes Patients with Insulin Therapy: A Study Based on Continuous Glucose Monitoring.
    Uemura F; Okada Y; Torimoto K; Tanaka Y
    Diabetes Technol Ther; 2018 Feb; 20(2):140-146. PubMed ID: 29293363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.